Latest filing published 03 Sept 2026 for Axsome Therapeutics, Inc., €112k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mark L. Jacobson: trading record in brief
Mark L. Jacobson appears in our data through filings on Axsome Therapeutics, Inc. shares, published by SEC (Form 4). We count 26 filings; the first trade dates from 1 April 2024 and the latest from 3 September 2026.
No open-market purchase appears, only 13 sales worth €25.1M. Outside the open market, there are 13 option exercises. So far in 2026, the count stands at no purchases and 4 sales.
Most recently, on 3 September 2026, the filings show an option exercise worth €112k in Axsome Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark L. Jacobson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$12.95Common StockSEC:0001193125-26-382277:0
- 10,000 shares@ US$208.65Common StockSEC:0001193125-26-382277:1
- 4,517 shares@ US$12.950.0005% mcap1.3% of flowCommon StockSEC:0001193125-26-207148:0
- 4,517 shares@ US$227.940.0095% mcap23.2% of flowCommon StockSEC:0001193125-26-207148:1
- 233 shares@ US$12.950.0000% mcap0.1% of flowCommon StockSEC:0001193125-26-207148:2
- 233 shares@ US$228.180.0005% mcap1.2% of flowCommon StockSEC:0001193125-26-207148:3
- 35,378 shares@ US$2.851.9% of flowCommon StockSEC:0001193125-26-083586:0
- 10,000 shares@ US$2.850.6% of flowCommon StockSEC:0001193125-25-211788:0
- 5,783 shares@ US$116.1912.9% of flowCommon StockSEC:0001193125-25-206494:0
- 25,000 shares@ US$110.4463.7% of flowCommon StockSEC:0000950170-25-084556:1
- 25,000 shares@ US$8.024.6% of flowCommon StockSEC:0000950170-25-084556:0
- 20,673 shares@ US$6.471.4% of flowCommon StockSEC:0000950170-25-078552:0
- 20,673 shares@ US$104.6622.6% of flowCommon StockSEC:0000950170-25-078552:1
- 20,000 shares@ US$6.471.4% of flowCommon StockSEC:0000950170-25-078552:2
- 20,000 shares@ US$103.4521.8% of flowCommon StockSEC:0000950170-25-078552:3
- 47,739 shares@ US$4.044.7% of flowCommon StockSEC:0000950170-24-094967:0
- 13,693 shares@ US$1.300.4% of flowCommon StockSEC:0000950170-24-066177:0
- 24,662 shares@ US$1.300.8% of flowCommon StockSEC:0000950170-24-039617:0
18 of 18 declarations
